Background. Acinetobacter baumannii is a pathogen of major importance in intensive care units worldwide, with the potential to cause problematic outbreaks and acquire high-level resistance to antibiotics. There is an urgent need to understand the mechanisms of A. baumannii pathogenesis for the future development of novel targeted therapies. In this study we performed an in vivo transcriptomic analysis of A. baumannii isolated from a mammalian host with bacteremia.
Acinetobacter baumannii is a gram-negative opportunistic pathogen responsible for a range of healthcare-associated infections, burn and wound infections, and communityacquired pneumonia [1, 2] . A. baumannii has a high degree of genome plasticity, conferring a propensity for the rapid acquisition of antibiotic resistance mechanisms. The escalating rate of outbreaks of disease in hospitals, particularly in intensive care units, combined with a diminishing armament of treatment options, has many investigators looking for novel means to prevent transmission and to treat A. baumannii infection [2] .
Despite increasing research efforts, a clear picture of the mechanisms of A. baumannii pathogenesis is still elusive [2] . Numerous virulence-related factors have been described, although much about the pathogenesis remains unknown. One promising method for discovery is through the analysis of whole-genome transcriptional profiles under different growth and environmental conditions. Previous analyses of the A. baumannii transcriptome have provided important insights into Acinetobacter biology, including growth in different phases and states ( planktonic cells vs biofilm) [3] , and response to serum [4] , iron limitation [5] , antibiotics [6] , and interaction with the Candida quorum sensing compound farnesol [7] . Regulatory networks of key transcriptional regulators (gacA, H-NS) have also been studied [8, 9] . However, no study has directly confronted the most important transcriptional response: what happens in vivo? In the current study, we analyzed the A. baumannii transcriptional response to the most important, life-threatening A. baumannii infection, bacteremia.
METHODS

Bacterial Strains and Culture Conditions
A. baumannii American Type Culture Collection (ATCC) 17978 was used for the mouse infection and transcriptomic analyses. Bacteria were grown overnight in LB medium at 37°C and were then washed and resuspended in phosphate-buffered saline before preparation of the infecting inoculum.
Experiments were approved by the Monash University Animal Ethics Committee. Two independent groups of mice (Balb/c, n = 3 per group) were inoculated with 5 × 10 5 colony-forming units (CFUs) of A. baumannii in 5% pig gastric mucin. After 8 hours, 100-400 µL of blood was collected per animal and placed in Trizol (Qiagen) for purification with the mirVana RNA purification kit (Ambion), followed by DNA removal with the Turbo DNA-free kit (Ambion). Bacteria were not separated from host cells before RNA purification. The mean bacterial densities in blood were 5 × 10 9 CFUs/mL for mice from group 1 and 10 9 CFUs/mL for those from group 2. Two control cultures (same inoculum) were grown in heart infusion medium (Oxoid) with aeration for the equivalent period of time (mean final bacterial density of 10 9 CFUs/mL). [13] . Biochemical pathways were explored using the resources at the BioCyc Web site [14] . Cluster of orthologous groups (COG) enrichment analysis was performed by dividing the percentage of genes up-or down-regulated for each category by the percentage of genes in that category across the whole genome [15] .
RESULTS AND DISCUSSION
A. baumannii Global Gene Expression Profile During Bacteremia
A. baumannii ATCC 17978 gene expression differed substantially between in vitro and in vivo environments. A total of 886 protein-coding genes were identified as differentially expressed by ≥2-fold (557 with increased expression, 329 with decreased expression) ( Figure 1 ). This accounts for approximately one-quarter of the A. baumannii ATCC 17978 genome (Supplementary Table 1 ). Analysis of the differentially expressed genes by COG category identified a high proportion with increased expression that encoded proteins involved in translation and ribosomal function (J), RNA processing (A), cell division (D), and DNA replication (L) ( Figure 2 ). Together these data suggest an increased growth rate for the bacteria in vivo compared with the in vitro culture. In contrast, genes encoding chaperones (O) were overrepresented in the down-regulated set, suggesting that they are less important for adaptation to the challenges of growing in vivo. Interestingly, whereas approximately one-quarter of the genome was differentially regulated, genes of the COG category transcription (K) were underrepresented.
Up-regulation of Iron Uptake Genes In Vivo
The majority of the genes showing highly increased in vivo expression were involved in iron import. Iron is essential for most bacteria and is highly restricted in the host environment as an innate immune defense mechanism; consequently, bacterial pathogens have evolved specific mechanisms for the acquisition of iron in vivo, including the synthesis of high-affinity iron chelating molecules called siderphores. A. baumannii ATCC 17978 has 3 clusters of genes involved in siderophore biosynthesis, along with multiple predicted siderophore import proteins [5] . Siderophore cluster 1 (A1S_1647-57; 5.5-124-fold change), siderophore cluster 2 (A1S_2562-81, 21-800-fold change), and the acinetobactin cluster (A1S_2372-92, 12-128-fold change) were all highly up-regulated in vivo, as well as a number of putative siderophore transport genes ( Figure 2) ; most of these genes showed very low or negligible expression in iron-replete medium in vitro. Similar transcriptional changes have been previously observed with iron limitation [5] ; most up-regulated genes were involved in siderophore synthesis and iron uptake. There were other notable differences between our in vivo transcriptional analysis and the in vitro low iron response; for example the hemerythrinlike protein (A1S_0891) was heavily down-regulated under iron limitation but unchanged in vivo. Furthermore, fumarase C showed unchanged expression in vivo but showed strongly increased expression (27-fold) with iron limitation. This clearly shows that although low iron levels are a critical component of the in vivo environment, other important signaling processes in vivo are shaping the global transcriptional response. Many genes involved in iron uptake were also up-regulated during growth in serum [4] and in biofilms [3] .
Expression of Genes Encoding Known Virulence Factors
Numerous A. baumannii virulence factors with diverse functions have been identified as necessary for full virulence in animal infection models (Supplementary Table 2) . Surprisingly, the majority of these factors showed either reduced or unchanged expression in vivo. There are a number of plausible explanations for this observation. First, these factors are specifically required for virulence, but in tissues other than blood. Second, these factors are specifically required for disease in blood but are differentially expressed at an earlier stage of septicemia. Third, they are required in some but not all infection models [40] , and the bacteremia model tested in the current study may differ from the model in which they were originally defined. Fourth, these factors may play a strain-specific role in virulence; the current study used ATCC 17978, whereas while other studies have used different strains of A. baumannii. For example, the type VI secretion systems of different strains of A. baumannii have different abilities to kill prokaryotic cells [22] . Finally, even expression at low levels might be sufficient to confer a virulence function. Indeed, reduced expression may be necessary under some circumstances such as immune evasion. For instance, OmpA is an outer membrane porin required for disease with a diverse range of ascribed roles (Supplementary Table 2 ). OmpA is also immunogenic, and antibodies specific to OmpA can confer immunity [41] . Hence, moderate down-regulation of OmpA may strike a balance between virulence function and immune evasion, allowing growth in vivo. Of particular interest are the genes that have a demonstrated association with survival in serum. Although ptk (capsule production) and pld ( phospholipase D) were up-regulated, the genes bfmSR (2 component signal transduction system), ompA (multifunction porin), cipA ( plasminogen binding), and pglC ( protein glycosylation and capsule synthesis), surprisingly, were either unchanged or down-regulated in vivo (Supplementary Table 2 ).
Changes in the Expression of Lipopolysaccharide and Capsule Biosynthesis Genes
A. baumannii capsule and lipopolysaccharide are important virulence factors [23, 34] . There were few changes in the expression of lipid A biosynthesis genes, with lpxC (A1S_3330) the only gene showing increased expression (3.8-fold increase). In the capsule locus (A1S_0049-66), the genes A1S_0049 (wzc/ ptk), A1S_0050 (tyrosine kinase/wzb), and A1S_0059 and A1S_0060 (glycosyltransferases) all showed enhanced transcription in vivo. Moreover, bfmR, which encodes a response regulator involved in the regulation (repression) of capsule biosynthesis, was down-regulated in vivo, which may have contributed to the expression changes observed in the capsule locus [42] . Notably, it has previously been shown that an increase in capsule synthesis through increased expression of several genes, including wzc/ptk, confers enhanced virulence [42] , suggesting that the transcriptional changes observed in this study may contribute to virulence. Increased capsule production may confer resistance to the bactericidal activity of complement, antimicrobial peptides, and phagocytosis.
Down-regulation of Biofilm and Pili Biosynthesis Genes In Vivo
Adhesins, quorum sensing proteins, and other survival-related genes, such as trehalose synthesis genes, were strongly downregulated in vivo. The type I pili assembly genes, csuA/B and csuA-E (A1S_2213-8), which are necessary for adhesion to abiotic surfaces and biofilm formation [43] , were all down-regulated in vivo. However, the type I pilus biosynthesis locus A1S_1507-10 was not differentially regulated in vivo but has previously been shown to be expressed at increased levels during growth under iron-limiting conditions [5] . A second pilus biosynthesis cluster (A1S_2088-91) had 1 strongly down-regulated gene in vivo (A1S_2091; 25-fold down). The reduced expression of type 1 pilus adhesion genes is reflected in the overrepresentation of differentially expressed genes in the COG category W genes (extracellular structures). Unsurprisingly, most type 1 pilus biosynthesis genes have been identified as up-regulated in biofilms [3] . The biofilm-associated proteins Bap (of which there are 2 orthologues in ATCC 17978 [18] ) were strongly down-regulated in the blood; in contrast, bap was overexpressed in biofilms [3] . Signaling pathways controlling biofilm formation were also down-regulated, including A1S_0748 (bfmR) [21] , A1S_1377, and A1S_1687 [3] . Likewise, the quorum sensing homoserine lactone synthase gene (abaI) and nearby locus (A1S_0109-16) required for biofilm formation [3] were down-regulated. As expected, these observations indicate that bacterial cells in blood are in a planktonic state.
Transcriptional Changes Related to Metabolism
A number of amino acid catabolism pathways, such as the phenylalanine ( paa), arginine (ast), and D alanine degradation (dada; A1S_0095) pathways were down-regulated. This may reflect the importance of amino acid catabolism as an energy source in protein-rich growth media such as heart infusion medium but less so in vivo. However, these data do not prove that these pathways do not play a role in virulence, because some down-regulated genes (such as those of the paa operon) have exceptionally high expression in vitro; hence, the reduced expression in vivo still corresponds to substantial levels of expression. Notably, many amino acid catabolism pathways have also been identified as up-regulated in biofilms [3] . The COG enrichment analysis indicated that many genes with predicted functions in lipid and carbohydrate transport/metabolism were expressed at reduced levels in vivo (Figure 2 ). These included 12 acyl-CoA dehyrogenases, beta-ketoadipyl-CoA thiolases (A1S_1849 and A1S_1891), 4 enoyl-CoA hydratase and/or isomerases, Acyl-CoA synthetase (A1S_0112) and long chain fatty-acid CoA ligase (A1S_1378). This suggests a metabolic shift away from fatty acids as an energy source in vivo.
In contrast, we observed a strong increase in expression of the lactate metabolism locus (A1S_0067-70) encoding a permease (30-fold increase), regulator and 2 lactate dehydrogenases (7-8-fold increase). Lactate dehydrogenase converts lactate to pyruvate, generating nicotinamide adenine dinucleotide, reduced. Pyruvate may enter the tricarboxylic acid cycle, although enzymes converting pyruvate to acetyl-CoA are down-regulated ( pyruvate dehydorgenase/decarboxylase aceE genes A1S_2450 and A1S_1701 and pyruvate-ferredoxin oxidoreductase gene A1S_1368). Because some gluconeogenesis enzymes are upregulated (eg, A1S_2596 fructose-1,6-bisphosphatase and A1S_2668 phophoenolpyruvate carboxykinase) it is possible that the lactate-to-pyruvate conversion is used for carbohydrate assimilation. Notably, lactate levels are elevated during human septicemia [44] and so may constitute an important carbon source.
Some components of other important biosynthetic pathways were also expressed at increased levels in vivo, including de novo nucleotide synthesis (reflected in COG category F, nucleotide transport and metabolism), which may reflect a change in nucleotide availability, peptidoglycan biosynthesis, isoprenoid precurser biosynthesis (which may feed into pathways such as lipid and ubiquinone synthesis), and pseudouridine synthases (modification of transfer RNAs). These changes also suggest an increased growth rate.
Comparison With the Altered Expression Profiles in Serum
It is of interest to analyze how the transcriptomic changes observed in vivo compare with those observed during growth in serum [4] . In serum, in addition to the expected siderophore synthesis clusters, 2 heme binding loci (A1S_1608-9) were up-regulated suggesting a role for heme as an iron source in vivo. However, these genes were not differentially regulated in our study, suggesting that heme is not an important iron source; ATCC 17978 also has no identifiable heme oxygenase for heme utilization. Type IV pili genes were also up-regulated in serum, suggesting that bacteria are primed to anchor to host tissue and invade, however, only 1 such gene was up-regulated in vivo. It was also suggested that DNA uptake and repair processes are enhanced in serum, perhaps for the acquisition of virulence genes, but in vivo most of the genes involved in these processes showed unchanged expression. Thus, we predict that there are multiple drivers regulating expression in vivo, because transcriptional changes in serum do not closely reflect those seen in vivo. Interestingly, 22 efflux pump genes were up-regulated in human serum, suggesting an enhanced drug export capacity in vivo with important implications for antibiotic treatment of A. baumannii infections. However, the in vivo situation was clearly different; of these 22 genes, 15 were unchanged, 2 were down-regulated, and 5 were up-regulated, but these are all part of siderophore clusters and probably have a role in siderophore extrusion (A1S_1649, A1S_2375-8) [5] .
CONCLUSION
Our results should be considered with the following caveats in mind. RNA sequencing measures RNA abundance, which is a product of both gene transcription and RNA stability. Differences in RNA abundance do not necessarily equate to differences in the levels of encoded product (ie, protein) or downstream metabolic processes due owing factors such as differences in translation efficiency and posttranscriptional regulation.
In conclusion, the current study illustrates the feasibility of in vivo transcriptomics for A. baumannii. As expected, there was a major shift in gene expression between the in vitro and in vivo growth conditions, emphasizing that in vitro growth is a poor reflection of a mammalian infection. Furthermore, it seems that in vivo growth only partly mirrors expression patterns seen in "in vivo-simulating" conditions, such as growth in serum or iron limitation. Future work should analyze transcriptomic changes in different tissues of the host and with different A. baumannii strains. Our findings should help future investigation of the virulence mechanisms for this problematic hospital-acquired pathogen.
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